Skip to content

ORKA

Oruka Therapeutics, Inc.

Stock

$84.52+1.10 (+1.32%)Close Oct 2, 2026

Free cash flow, 2025
−$88M

Free cash flow

Free cash flow by fiscal year

PeriodFree cash flowYoY
2025−$88M—
2023−$5.0M—
2022−$11M—
2021−$19M—
2020−$7.7M—
2019−$4.8M—
2018−$8.2M—
2017−$17M—
2016−$15M—
2015−$11M—
2014−$9.4M—
2013−$5.3M—
2011−$7.0M—
2010−$8.3M—